Premium
Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy risk
Author(s) -
Marignier Romain,
DurandDubief Françoise,
du Pasquier Renaud,
Vukusic Sandra
Publication year - 2016
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.24768
Subject(s) - medicine , natalizumab , clinical neurology , neurology , humanities , multiple sclerosis , psychology , psychiatry , neuroscience , art
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom